Press Releases

AARDEX Group Announced as Founder Member of CancerX Initiative to Drive Innovation in the Fight Against Cancer

AARDEX Group Announced as Founder Member of CancerX Initiative to Drive Innovation in the Fight Against Cancer Adherence specialists join multi-stakeholder initiative to improve long-term pathways for cancer patients and meet the challenge of oral treatments.

Upperton completes build of new £15m development and GMP manufacturing facility

Cytel acquires French group stève consultants to further expand value evidence and real-world analytics capabilities

Cytel Inc. has acquired stève consultants, specialists in market access, real-world (RWE), and health economics and outcomes research.

Skyelarke furthers its mission to break down barriers to clinical trial participation, with new SkyePay enhancements

Skyelarke furthers its mission to break down barriers to clinical trial participation, with new SkyePay enhancements Cary, North Carolina- July 11th, 2023: Skyelarke, a health tech company, has announced some significant new additions to SkyePay, a cutting-edge patient payment technology built by and for the clinical research industry.

Phastar's B Corp™ certification affirms its status as a 'force for good' organization

Phastar's B Corp™ certification affirms its status as a 'force for good' organization International certification recognizes leading global specialist biometrics CRO’s commitment and leadership in corporate social responsibility and sustainable business practices.

Kindeva Drug Delivery, Chiesi Group, and H&T Presspart Announce Strategic Partnership for Dose Counter Technology Production

Kindeva Drug Delivery, a global leader in contract drug delivery development and manufacturing services and technology, and H&T Presspart (a division of the Heitkamp & Thumann Group), a market leader in respiratory drug delivery systems design, development, and manufacturing, are partnering with Chiesi Group, an international research-focused biopharmaceutical and healthcare group, for the installation of a production line for dose counter (DC) and dose indicator (DI) devices. Combining the specific expertise of each partner, H&T Presspart will manufacture Kindeva Drug Delivery’s dose counters under license for Chiesi Group for their pressurized metered-dose inhaler (pMDI) portfolio.

Pharma Targeting Launch ‘Partner Identifier’ to Intelligently Connect the Dots between Data and Business Opportunity for Pharma Clients

Pharma Targeting, part of the The Targeting Group and a leading global pharmaceutical market intelligence and data company, has unveiled its latest pioneering initiative, designed to help pharma and biotech companies find the partners they need to get funded, noticed, and faster to market. The service uses data-driven intelligence to help customers identify and engage with the right partner, whether it be for licencing, in-licensing, funding, distribution, or any other business need.

VitaDAO Launches VITA-FAST Tokens, Revolutionizing Governance in Longevity Research

VitaDAO has announced the launch of the VITA-FAST tokens.

LILLY RECEIVES MHRA MARKETING AUTHORISATION IN GREAT BRITAIN FOR MIRIKIZUMAB (OMVOH ®▼) FOR THE TREATMENT OF ELIGIBLE ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

ENPICOM secures extended financing from BOP Capital, BOM Brabant Ventures, Nextgen Ventures, and Arches Capital

ENPICOM has successfully secured further financial backing from its current investors BOP Capital, BOM Brabant Ventures, Nextgen Ventures, and Arches Capital.

Tower Cold Chain Expands Presence with Opening of American Centre of Excellence

Pharmaceutical thermal protection specialist Tower Cold Chain has opened its new headquarters in the Americas region.

Meissa Vaccines Enters into CGMP Manufacturing Agreement for Pediatric RSV Vaccine Candidate for Phase 2 Clinical Trials

Meissa Vaccines has announced it has entered into a manufacturing agreement with Exothera S.A. to manufacture Meissa’s MV-012-968 vaccine candidate under Current Good Manufacturing Practice regulations to supply Phase 2 clinical trials.

Cresset Creates New Vice President Role to Lead their Discovery CRO Business

Drug discovery computer software specialists Cresset have made a major new addition to their senior leadership with the appointment of Nick Foster as Vice President of their Discovery CRO business.

OMAPiX Announces Strategic Partnerships with Leading Spatial Biology Platform Providers to Accelerate Life Science Research and Drug Development

OMAPiX announces strategic collaborations with Vizgen, Resolve Biosciences, and Ultivue as part of its ongoing commitment to expand its services portfolio in Europe and North America.

Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET technology

Oncodesign Services has announced the execution of a Preclinical License and Supply Agreement with ImaginAb Inc. for the use of their investigational CD8 ImmunoPETTM (89Zr crefmirlimab berdoxam) technology.

Pharma Targeting launches FMCG Targeting

Pharma Targeting launches FMCG Targeting Exclusive offer for FMCG service providers increases requests for proposals and helps clients be first to market.

Dr. Vince Clinical Research Now Green Certified

Dr. Vince Clinical Research, a full-service Phase I-II contract research organization (CRO), announced its world-class clinical pharmacology unit, which opened in September, was awarded two Green Globes certifications.

Spaulding Clinical Expands Services to Include ADME Clinical Trials

Spaulding Clinical, a leading clinical research organization (CRO), is expanding its services to include ADME (absorption, distribution, metabolism, and excretion) clinical trials

Elligo Health Research Partners With Mindful Health Solutions to Bring Technology-Enabled Clinical Research Services to Clinics Across the U.S.

Elligo Health Research®, the largest healthcare-enabling research organization, announced they have entered into a new partnership with Mindful Health Solutions, a professional medical corporation focused on treating depression and mental health conditions. Through this partnership, Elligo will provide its technology-powered research services to Mindful Health Solutions’ clinics across the U.S., enabling their participation in industry-sponsored clinical trials.

CD Formulation Expands Its Healthcare Product Development and OEM/ODM Services